Irinotel 40 mg Injection
4,77$
3,84$
Irinotel 40 mg injection is a powerful topoisomerase inhibitor designed to combat advanced colorectal cancer effectively. This injectable medication is often prescribed as part of a combination therapy, particularly with 5-fluorouracil and folinic acid, for patients who have not undergone prior chemotherapy for advanced disease. Irinotecan, the active component in Irinotel, works by interfering with the DNA replication process in cancer cells, ultimately leading to cell death. It can be used alone or alongside other treatments as a first-line option for individuals diagnosed with metastatic carcinoma of the colon or rectum. While Irinotel offers promising benefits, it is essential to be aware of potential side effects, such as diarrhea and low blood cell counts, which may require monitoring during treatment. Patients should discuss their medical history and any existing medications with their healthcare provider to avoid adverse interactions. This medication represents a vital option in the fight against colorectal cancer, providing hope and improved outcomes for many patients.
Quantité
Active Pharmaceutical Ingredient
Uses
• Irinotel 40 mg injection is primarily used in the treatment of certain types of cancer, particularly metastatic colorectal cancer. It works by inhibiting cancer cell growth and promoting their death, which is crucial in managing this disease. Patients often receive Irinotel 40 mg injection as part of a combination chemotherapy regimen. This approach enhances the overall effectiveness of treatment and targets cancer cells more efficiently.
• In addition to colorectal cancer, Irinotel 40 mg injection may also be utilized in treating other solid tumors, as determined by the healthcare provider. The administration of this medication is typically done in a hospital or clinical setting by qualified medical professionals. This ensures that patients receive the appropriate monitoring and support during treatment. The specific use of Irinotel 40 mg injection can be tailored based on individual patient factors and cancer characteristics.
• The effectiveness of Irinotel 40 mg injection is often maximized when used alongside other chemotherapy agents. This combination therapy can help overcome cancer resistance and improve patient outcomes. Oncologists evaluate the patient's overall health and cancer progression to develop a personalized treatment plan that includes Irinotel 40 mg injection. This strategic approach aims to enhance the chances of successful treatment while managing the disease more effectively.
• Healthcare providers may recommend Irinotel 40 mg injection for patients whose cancer has not responded to other treatment options. It serves as an alternative therapeutic choice in challenging cases. The intravenous administration allows for rapid absorption and action within the body. By utilizing Irinotel 40 mg injection, oncologists aim to provide patients with a viable option to manage their cancer effectively.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irinotel 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Anti-cancer Drug Irinotel can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Irinotecan Injection 40 mg is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irinotel 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irinotel 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irinotel 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Irinotel 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Irinotel 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of Irinotel 40 mg Vial therapy.
• Liver: Irinotecan Injection 40 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Anti-cancer Drug Irinotel and report any unusual symptoms or changes in liver function to their doctor. The dose of Irinotel 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Irinotecan Injection 40 mg has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irinotel 40 mg, Irinotel 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Irinotel Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irinotel 40 mg Injection.
• Driving: Irinotel 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Irinotel Injection, and advised not to drive or operate machinery if these symptoms occur.